Progressive parenchymal deposition of β-amyloid precursor protein in rat brain following global cerebral ischemia

Baowan Lin, Rainald Schmidt-Kastner, Raul Busto, Myron Ginsberg

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

In addition to producing acute neuronal necrosis within selectively vulnerable brain regions, our recent studies have shown that global cerebral ischemia may also be followed by protracted degenerative changes occurring over the course of 10 weeks. Chronic brain pathology may be associated with the abnormal deposition of β-amyloid precursor protein (βAPP). In the present study, we used a monoclonal antibody to the N-terminal portion of βAPP to characterize the brains of rats surviving 1-10 weeks following 10 min of global brain ischemia produced by bilateral carotid artery occlusions plus systemic hypotension. After ischemia, increased βAPP immunolabeling emerged in several brain regions. In the hippocampus, granular deposits appeared in the damaged CA 1 area by 2 weeks, and by 4-10 weeks the remnants of necrotic CA1 neurons were also immunolabeled. In striatum and thalamus, regions with necrotic cell death also revealed granular βAPP deposits. The neocortex was devoid of overt ischemic neuronal damage bur revealed prominent βAPP immunoreactivity. Large ovoid deposits of low-density βAPP immunostaining occurred in cortical neurons at 1-2 weeks. At 4-10 weeks, large round or oval deposits immunoreactive for βAPP appeared in several cortical regions. The highest density of deposits was seen in the temporal and piriform cortices. Our results indicate that abnormal βAPP deposition may result from ischemic as well as chronic neurodegenerative processes.

Original languageEnglish
Pages (from-to)359-368
Number of pages10
JournalActa Neuropathologica
Volume97
Issue number4
DOIs
StatePublished - Apr 1 1999

Fingerprint

Amyloid beta-Protein Precursor
Brain Ischemia
Brain
Neurons
Neocortex
Temporal Lobe
Thalamus
Carotid Arteries
Hypotension
Hippocampus
Cell Death
Necrosis
Ischemia
Monoclonal Antibodies
Pathology

Keywords

  • Amyloid
  • Chronic pathology
  • Immunochemistry
  • Neurodegeneration

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Progressive parenchymal deposition of β-amyloid precursor protein in rat brain following global cerebral ischemia. / Lin, Baowan; Schmidt-Kastner, Rainald; Busto, Raul; Ginsberg, Myron.

In: Acta Neuropathologica, Vol. 97, No. 4, 01.04.1999, p. 359-368.

Research output: Contribution to journalArticle

@article{294da113362b4003a34e09a815bd2d42,
title = "Progressive parenchymal deposition of β-amyloid precursor protein in rat brain following global cerebral ischemia",
abstract = "In addition to producing acute neuronal necrosis within selectively vulnerable brain regions, our recent studies have shown that global cerebral ischemia may also be followed by protracted degenerative changes occurring over the course of 10 weeks. Chronic brain pathology may be associated with the abnormal deposition of β-amyloid precursor protein (βAPP). In the present study, we used a monoclonal antibody to the N-terminal portion of βAPP to characterize the brains of rats surviving 1-10 weeks following 10 min of global brain ischemia produced by bilateral carotid artery occlusions plus systemic hypotension. After ischemia, increased βAPP immunolabeling emerged in several brain regions. In the hippocampus, granular deposits appeared in the damaged CA 1 area by 2 weeks, and by 4-10 weeks the remnants of necrotic CA1 neurons were also immunolabeled. In striatum and thalamus, regions with necrotic cell death also revealed granular βAPP deposits. The neocortex was devoid of overt ischemic neuronal damage bur revealed prominent βAPP immunoreactivity. Large ovoid deposits of low-density βAPP immunostaining occurred in cortical neurons at 1-2 weeks. At 4-10 weeks, large round or oval deposits immunoreactive for βAPP appeared in several cortical regions. The highest density of deposits was seen in the temporal and piriform cortices. Our results indicate that abnormal βAPP deposition may result from ischemic as well as chronic neurodegenerative processes.",
keywords = "Amyloid, Chronic pathology, Immunochemistry, Neurodegeneration",
author = "Baowan Lin and Rainald Schmidt-Kastner and Raul Busto and Myron Ginsberg",
year = "1999",
month = "4",
day = "1",
doi = "10.1007/s004010050999",
language = "English",
volume = "97",
pages = "359--368",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Progressive parenchymal deposition of β-amyloid precursor protein in rat brain following global cerebral ischemia

AU - Lin, Baowan

AU - Schmidt-Kastner, Rainald

AU - Busto, Raul

AU - Ginsberg, Myron

PY - 1999/4/1

Y1 - 1999/4/1

N2 - In addition to producing acute neuronal necrosis within selectively vulnerable brain regions, our recent studies have shown that global cerebral ischemia may also be followed by protracted degenerative changes occurring over the course of 10 weeks. Chronic brain pathology may be associated with the abnormal deposition of β-amyloid precursor protein (βAPP). In the present study, we used a monoclonal antibody to the N-terminal portion of βAPP to characterize the brains of rats surviving 1-10 weeks following 10 min of global brain ischemia produced by bilateral carotid artery occlusions plus systemic hypotension. After ischemia, increased βAPP immunolabeling emerged in several brain regions. In the hippocampus, granular deposits appeared in the damaged CA 1 area by 2 weeks, and by 4-10 weeks the remnants of necrotic CA1 neurons were also immunolabeled. In striatum and thalamus, regions with necrotic cell death also revealed granular βAPP deposits. The neocortex was devoid of overt ischemic neuronal damage bur revealed prominent βAPP immunoreactivity. Large ovoid deposits of low-density βAPP immunostaining occurred in cortical neurons at 1-2 weeks. At 4-10 weeks, large round or oval deposits immunoreactive for βAPP appeared in several cortical regions. The highest density of deposits was seen in the temporal and piriform cortices. Our results indicate that abnormal βAPP deposition may result from ischemic as well as chronic neurodegenerative processes.

AB - In addition to producing acute neuronal necrosis within selectively vulnerable brain regions, our recent studies have shown that global cerebral ischemia may also be followed by protracted degenerative changes occurring over the course of 10 weeks. Chronic brain pathology may be associated with the abnormal deposition of β-amyloid precursor protein (βAPP). In the present study, we used a monoclonal antibody to the N-terminal portion of βAPP to characterize the brains of rats surviving 1-10 weeks following 10 min of global brain ischemia produced by bilateral carotid artery occlusions plus systemic hypotension. After ischemia, increased βAPP immunolabeling emerged in several brain regions. In the hippocampus, granular deposits appeared in the damaged CA 1 area by 2 weeks, and by 4-10 weeks the remnants of necrotic CA1 neurons were also immunolabeled. In striatum and thalamus, regions with necrotic cell death also revealed granular βAPP deposits. The neocortex was devoid of overt ischemic neuronal damage bur revealed prominent βAPP immunoreactivity. Large ovoid deposits of low-density βAPP immunostaining occurred in cortical neurons at 1-2 weeks. At 4-10 weeks, large round or oval deposits immunoreactive for βAPP appeared in several cortical regions. The highest density of deposits was seen in the temporal and piriform cortices. Our results indicate that abnormal βAPP deposition may result from ischemic as well as chronic neurodegenerative processes.

KW - Amyloid

KW - Chronic pathology

KW - Immunochemistry

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=0032972815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032972815&partnerID=8YFLogxK

U2 - 10.1007/s004010050999

DO - 10.1007/s004010050999

M3 - Article

C2 - 10208275

AN - SCOPUS:0032972815

VL - 97

SP - 359

EP - 368

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 4

ER -